We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Ablynx, Merck & Co. Expand Immuno-Oncology Collaboration

News   Jul 23, 2015

 
Ablynx, Merck & Co. Expand Immuno-Oncology Collaboration
 
 
 

RELATED ARTICLES

Marathon-running Molecule Set to Accelerate the Race for Novel Neurological Drugs

News

Two proteins that activate the fastest molecule in our nerve cells have been identified by researchers at University of Warwick. This mechanism is responsible for transport through our nervous system. This finding could lead to a new therapeutic treatments for people with hereditary spastic paraplegia and other neurological disorders.

READ MORE

Controlling HIV Infection by Reprogramming Immune Cells

News

Scientists have described the characteristics of CD8 immune cells in "HIV controller" patients and used the information on the unique antiviral power of these immune cells to reprogramme cells from individuals who can't fight the infection.

READ MORE

Preventing Protein From “Doing Its Job” Could Stop Ovarian Cancer Cells From Spreading

News

By preventing a protein from doing its job, researchers discovered that it may be possible to keep a certain type of ovarian cancer cell from growing and dividing uncontrollably.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE